A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1

INTRODUCTION: As the only market-authorized allergen immunotherapy (AIT) for peanut allergy is accompanied by a high risk of side effects and mainly induces robust desensitization without sustained efficacy, novel treatment options are required. Peanut-specific plant-derived eBioparticles (eBPs) sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Castenmiller, Charlotte, Nagy, Noémi Anna, Kroon, Pascal Zion, Auger, Lydia, Desgagnés, Réjean, Martel, Caroline, Mirande, Lucie, Morel, Bertrand, Roberge, Joannie, Stordeur, Virginie, Tropper, Guy, Vézina, Louis Philipe, van Ree, Ronald, Gomord, Véronique, de Jong, Esther Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2023
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679945/
https://www.ncbi.nlm.nih.gov/pubmed/38020282
http://dx.doi.org/10.1016/j.waojou.2023.100839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679945/
https://www.ncbi.nlm.nih.gov/pubmed/38020282
http://dx.doi.org/10.1016/j.waojou.2023.100839

Ejemplares similares